Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34752
Title: Thymic Carcinoid in a Patient with Concurrent Manifestations of Multiple Endocrine Neoplasia Type 1.
Austin Authors: Zhu, Jasmine J ;Dean, Samantha;Hafeez, Umbreen ;Neoh, Sandra L 
Affiliation: Endocrinology
Medical Oncology
Melbourne Medical School, University of Melbourne, Parkville, VIC 3010, Australia.;Department of Oncology, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084, Australia.;School of Cancer Medicine, La Trobe University, Plenty Road and Kingsbury Dr, Bundoora, VIC 3086, Australia.
Issue Date: 2023
Date: 2023
Publication information: Case Reports in Endocrinology 2023; 2023
Abstract: Thymic carcinoid tumours, especially in the context of multiple endocrine neoplasia type 1 (MEN 1), present significant clinical challenges due to their rarity and aggressive nature. This case report describes a complex patient with MEN 1, who suffered from multiple manifestations of the disease, including thymic carcinoid. The tumour was initially resected and treated with adjuvant radiotherapy. Due to slow progression over the years, the tumour was treated with two lines of chemotherapy before the patient succumbed to progressive disease. There is currently limited evidence favoring any specific medical treatment for thymic carcinoid.
URI: https://ahro.austin.org.au/austinjspui/handle/1/34752
DOI: 10.1155/2023/8801080
ORCID: 0000-0003-2309-5156
0000-0001-8183-4119
0000-0001-7963-6367
0000-0001-9387-7079
Journal: Case Reports in Endocrinology
Start page: 8801080
PubMed URL: 38116541
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

14
checked on Nov 5, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.